479 related articles for article (PubMed ID: 34307372)
1. Stem Cell Therapies for Progressive Multiple Sclerosis.
Smith JA; Nicaise AM; Ionescu RB; Hamel R; Peruzzotti-Jametti L; Pluchino S
Front Cell Dev Biol; 2021; 9():696434. PubMed ID: 34307372
[TBL] [Abstract][Full Text] [Related]
2. Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.
Pluchino S; Smith JA; Peruzzotti-Jametti L
Trends Mol Med; 2020 Oct; 26(10):898-912. PubMed ID: 32448751
[TBL] [Abstract][Full Text] [Related]
3. Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how.
Szczechowski L; Śmiłowski M; Helbig G; Krawczyk-Kuliś M; Kyrcz-Krzemień S
Int J Neurosci; 2016 Oct; 126(10):867-71. PubMed ID: 26577419
[TBL] [Abstract][Full Text] [Related]
4. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
Front Immunol; 2020; 11():668. PubMed ID: 32431694
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for relapsing-remitting multiple sclerosis.
He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
[TBL] [Abstract][Full Text] [Related]
6. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.
Nandoskar A; Raffel J; Scalfari AS; Friede T; Nicholas RS
Drugs; 2017 May; 77(8):885-910. PubMed ID: 28429241
[TBL] [Abstract][Full Text] [Related]
8. Siponimod for the treatment of secondary progressive multiple sclerosis.
Dumitrescu L; Constantinescu CS; Tanasescu R
Expert Opin Pharmacother; 2019 Feb; 20(2):143-150. PubMed ID: 30517042
[TBL] [Abstract][Full Text] [Related]
9. Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis.
Pearse DD; Hefley AB; Morales AA; Ghosh M
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740263
[TBL] [Abstract][Full Text] [Related]
10. Teriflunomide for multiple sclerosis.
He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Progressive Multiple Sclerosis.
Macaron G; Ontaneda D
Biomedicines; 2019 Jul; 7(3):. PubMed ID: 31362384
[TBL] [Abstract][Full Text] [Related]
12. Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.
Haschka D; Tymoszuk P; Bsteh G; Petzer V; Berek K; Theurl I; Berger T; Weiss G
Front Immunol; 2020; 11():594. PubMed ID: 32411125
[TBL] [Abstract][Full Text] [Related]
13. Teriflunomide for multiple sclerosis.
He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
[TBL] [Abstract][Full Text] [Related]
14. High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis.
Freeman L; Longbrake EE; Coyle PK; Hendin B; Vollmer T
CNS Drugs; 2022 Dec; 36(12):1285-1299. PubMed ID: 36350491
[TBL] [Abstract][Full Text] [Related]
15. Progressive Multiple Sclerosis.
Willis MA; Fox RJ
Continuum (Minneap Minn); 2016 Jun; 22(3):785-98. PubMed ID: 27261682
[TBL] [Abstract][Full Text] [Related]
16. The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
Amoriello R; Greiff V; Aldinucci A; Bonechi E; Carnasciali A; Peruzzi B; Repice AM; Mariottini A; Saccardi R; Mazzanti B; Massacesi L; Ballerini C
Front Immunol; 2020; 11():559. PubMed ID: 32328061
[TBL] [Abstract][Full Text] [Related]
17. What is new in the treatment of multiple sclerosis?
Weinstock-Guttman B; Jacobs LD
Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827
[TBL] [Abstract][Full Text] [Related]
18. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
[TBL] [Abstract][Full Text] [Related]
19. Laquinimod for multiple sclerosis.
He D; Han K; Gao X; Dong S; Chu L; Feng Z; Wu S
Cochrane Database Syst Rev; 2013 Aug; (8):CD010475. PubMed ID: 23922214
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
